In this issue:
- DELIVER trial: dapagliflozin in HF
- REVIVED trial: PCI vs. optimal medical therapy in LVEF & CAD
- AI vs. sonographer evaluations of LVEF scans
- ADVOR trial: acetazolamide in acute decompensated HF
- SECURE trial: polypill approach following MI
- Morning vs. evening dosing of blood-pressure medication
- Population-based CV disease screening in Denmark
- Adverse muscle events in statin therapy
- PANTHER trial: P2Y12 inhibitor vs. aspirin monotherapy in CAD
- INVICTUS trial: adverse CV events with rivaroxaban
- POST-PCI trial: routine functional testing vs. standard care after PCI
- DANFLU-1 trial: high- vs. standard-dose influenza vaccine in adults ≥65 yrs
Please login below to download this issue (PDF)